TrialScientific reports2025

Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I.

Ali Rabbani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.